Managing Risk in Asia #6: Managing transactional risks in life science investments in Asia
Supported by increasing demand, partially fuelled by the impact of COVID-19, recent years have seen the life sciences sector develop into a critical growth area in Asia Pacific, which is home to approximately 60% of the world’s population. As a result, global investors are increasingly looking at opportunities in the region to capitalise on the demand. At the same time, Asian investors are increasingly expanding their footprint outside Asia Pacific.
In this episode, our speakers cover:
Create your
podcast in
minutes
It is Free